Recent Finacing
Recent Raise
HilleVax, created by Takeda and Frazier, is a biotech advancing a late-stage vaccine program, led by CEO Rob Hershberg and supported by an A-list board.
Focus Areas
Recent Investors
Total Raised
Funding round
See the team members at HilleVax.
